7 research outputs found
Retention of adolescents living with HIV in care, treatment, and support programs in Uganda
Understanding the extent to which adolescents aged 10â19 years who are living with HIV are retained in HIV care, treatment, and support is important for informing the design of effective services for this population to better meet their needs across three main areas of HIV and AIDS programming: treatment; care and support; and prevention. Retention in HIV programs is, in turn, important for positive clinical outcomes including viral suppression and survival. In 2013â2014, The AIDS Support Organization and the Population Council undertook a study to generate evidence on factors associated with retention of adolescents in HIV and AIDS programs in Uganda. The study was conducted under the USAID HIVCore project led by the Council, and responded to WHO and UNFPA guidelines on care, treatment, and support for women living with HIV and AIDS and their children in resource-constrained settings that emphasize ensuring availability of age-appropriate information and counseling on SRH and safer sexual practices, and offering adolescent-friendly family planning counseling and services. The goal was to generate evidence on the level of, and factors associated with, retention of HIV-positive adolescents in HIV and AIDS programs in Uganda
Factors associated with longâterm antiretroviral therapy attrition among adolescents in rural Uganda: a retrospective study
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/138247/1/jia20841.pd
Lessons learned and study results from HIVCore, an HIV implementation science initiative
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/138261/1/jia21261.pd
Factors associated with long-term antiretroviral therapy attrition among adolescents in rural Uganda: a retrospective study
Retrospective review of task-shifting community-based programs supporting ARV treatment and retention in Uganda
The purpose of this study was to examine examples of task-shifting programs in Uganda with the aim of generating data that could inform the development of task-shifting policies, guidelines, and practices. The overall purpose of the study was to contribute to the growing knowledge base about task-shifting by describing the service delivery approaches of three purposively selected major AIDS service organizations (ASOs) in Uganda that have adopted task-shifting. The study showed that in the three ASOs, almost all key tasks in antiretroviral therapy (ART), including determining eligibility, initiating ART, and dispensing antiretrovirals, can be feasibly shifted to lower-level cadres or facilities. It also identified training gaps in specific areas of competence among professional health workers and lay health workers currently providing ART in task-shifted services. Findings from this study provide important insight on costs and outcomes associated with task-shifting in facility-based versus outreach/community-based service environments. The report concludes with a number of recommendations based on these findings
Afri-Can Forum 2
CITATION: Mukudu, H., et al. 2016. Afri-Can Forum 2. BMC Infectious Diseases, 16:315, doi:10.1186/s12879-016-1466-6.The original publication is available at https://bmcinfectdis.biomedcentral.comENGLISH ABSTRACT: We are pleased to present peer reviewed forum proceedings of the 2nd synchronicity forum of GHRI/CHVIfunded Canadian and
African HIV prevention and vaccine teams
Forum objectives
âGHRI-funded capacity building and HIV prevention research teams presented highlights of achievements
âTeams discussed how to jointly build on achievements for sustainability
âProvided an opportunity for inter-team collaboration,
synchronize best approach to capacity building, mentoring of new researchers and building leadership
âProvided opportunities for informal discussions and networking among the teams.
âTeams learnt about recent advances in the area of African regulatory and ethics review process
âThe forum proceedings was a special supplement in an openaccess journal was producedhttps://bmcinfectdis.biomedcentral.com/articles/supplements/volume-16-supplement-2Publisher's versio